[Systemic sclerosis: drugs and new therapeutic methods].
The purpose of our review is to present conventional drugs as well as innovative treatment concepts for systemic sclerosis, particularly with their effects on the most important pathogenetic mechanisms of this disease. Date from literature indicates that all therapeutic methods are connected with occurrence of side effects, therefore in our paper we focused on benefits and disadvantages of therapeutic options for systemic sclerosis.
Skretkowicz
Kamila
K
Zakład Farmakologii Katedry Farmakologii Akademii Medycznej w Łodzi.
Waszczykowska
Elzbieta
E
Dziankowska-Bartkowiak
Bozena
B
D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D007371:Interferon-gamma; D010406:Penicillins; D017367:Selective Serotonin Reuptake Inhibitors; D013792:Thalidomide